MedTrace Logo

Characterization of Methylation Patterns in Hepatocellular Carcinoma

NCT04264754 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-05-06

No results posted yet for this study

Summary

This study is being performed as part of the development process of the Liver EpiCheck test which includes the identification of different methylation profiles in HCC (hepatocellular carcinoma) patients compare to cancer free control in blood samples

Conditions

Interventions

PROCEDURE

Blood collection

Peripheral blood will be collected via routine venipuncture procedure

Sponsors & Collaborators

  • Nucleix Ltd.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-13
Primary Completion
2021-02-01
Completion
2021-02-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04264754 on ClinicalTrials.gov